With the UK leaving the EU, Haig was asked about the potential impact on Life Sciences and has written an article published in the Pharma’s Almanac on the importance of staying ahead of the curve and accelerating innovation in spite of the upcoming regulatory change turbulence.
See the full article here:
PA_Q120_152_Haig_v0PA_Q120_152_Haig_v1
Source – Pharma’s Almanac